Related Experiment Video

Updated: Feb 10, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.2K

Mitochondrial transplantation: applications for pediatric patients with congenital heart disease

Sitaram M Emani1, James D McCully1

  • 1Department of Cardiovascular Surgery, Boston Children's Hospital, Boston, USA.

Translational Pediatrics
|May 18, 2018
PubMed

Insights

Mitochondrial transplantation, using healthy mitochondria to repair injured tissue, shows promise for pediatric heart recovery. Initial studies indicate a safe and effective approach for myocardial dysfunction following ischemia and reperfusion.

Area of Science:

  • Regenerative Medicine
  • Mitochondrial Biology
  • Cardiology

Background:

  • Ischemia and reperfusion (I/R) injury commonly causes myocardial dysfunction.
  • Mitochondrial dysfunction is a key factor in I/R injury.
  • Mitochondrial transplantation is an emerging therapeutic strategy.

Purpose of the Study:

  • To review preclinical and initial clinical experiences of mitochondrial transplantation.
  • To evaluate the efficacy and safety of this technique in pediatric patients with myocardial dysfunction.

Main Methods:

  • Transplantation of respiratory competent mitochondria into injured tissues.
  • Application in pediatric patients experiencing myocardial I/R injury.
  • Utilizing extracorporeal membrane oxygenation (ECMO) support.

Main Results:

  • Favorable efficacy observed in a small cohort of pediatric patients.
  • Low side effect profile reported.
  • Successful recovery of myocardial function post-transplantation.

Conclusions:

  • Mitochondrial transplantation is a potentially effective treatment for pediatric myocardial dysfunction.
  • The technique demonstrates a promising safety profile.
  • Further research is warranted to validate these initial findings.

Keywords:
Mitochondriaextracorporeal membrane oxygenation (ECMO)

More Related Videos

A Modified Method for Heterotopic Mouse Heart Transplantion11:29

A Modified Method for Heterotopic Mouse Heart Transplantion

Published on: June 23, 2014

13.2K
Optimization of the Cuff Technique for Murine Heart Transplantation14:01

Optimization of the Cuff Technique for Murine Heart Transplantation

Published on: June 26, 2020

10.1K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
330
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
245
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
307
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
554
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K